ArticleThe Lancet. Haematology2021

Minimal residual disease, long-term outcome, and IKZF1 deletions in children and adolescents with Down syndrome and acute lymphocytic leukaemia: a matched cohort study.

Naomi Michels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.